Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126396311 | 12639631 | 1 | I | 20100611 | 20160804 | 20160810 | 20160810 | EXP | DE-ROCHE-1809461 | ROCHE | 44.01 | YR | M | Y | 0.00000 | 20160810 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126396311 | 12639631 | 1 | PS | Rituximab | RITUXIMAB | 1 | Unknown | U | 103705 | ||||||||||
| 126396311 | 12639631 | 2 | SS | Rituximab | RITUXIMAB | 1 | U | 103705 | |||||||||||
| 126396311 | 12639631 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 0 | |||||||||||
| 126396311 | 12639631 | 4 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | 0 | ||||||||||||
| 126396311 | 12639631 | 5 | SS | CYTARABINE. | CYTARABINE | 1 | Unknown | 0 | |||||||||||
| 126396311 | 12639631 | 6 | SS | CYTARABINE. | CYTARABINE | 1 | 0 | ||||||||||||
| 126396311 | 12639631 | 7 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | 0 | |||||||||||
| 126396311 | 12639631 | 8 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | 0 | ||||||||||||
| 126396311 | 12639631 | 9 | SS | MELPHALAN | MELPHALAN | 1 | Unknown | 0 | |||||||||||
| 126396311 | 12639631 | 10 | SS | MELPHALAN | MELPHALAN | 1 | 0 | ||||||||||||
| 126396311 | 12639631 | 11 | SS | CARMUSTINE | CARMUSTINE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126396311 | 12639631 | 1 | Malignant lymphoid neoplasm |
| 126396311 | 12639631 | 2 | Mantle cell lymphoma |
| 126396311 | 12639631 | 3 | Malignant lymphoid neoplasm |
| 126396311 | 12639631 | 4 | Mantle cell lymphoma |
| 126396311 | 12639631 | 5 | Malignant lymphoid neoplasm |
| 126396311 | 12639631 | 6 | Mantle cell lymphoma |
| 126396311 | 12639631 | 7 | Malignant lymphoid neoplasm |
| 126396311 | 12639631 | 8 | Mantle cell lymphoma |
| 126396311 | 12639631 | 9 | Malignant lymphoid neoplasm |
| 126396311 | 12639631 | 10 | Mantle cell lymphoma |
| 126396311 | 12639631 | 11 | Malignant lymphoid neoplasm |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126396311 | 12639631 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126396311 | 12639631 | C-reactive protein increased | |
| 126396311 | 12639631 | Febrile bone marrow aplasia | |
| 126396311 | 12639631 | General physical health deterioration | |
| 126396311 | 12639631 | Staphylococcus test positive |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126396311 | 12639631 | 3 | 20100528 | 20100603 | 0 | |
| 126396311 | 12639631 | 5 | 20100528 | 20100603 | 0 | |
| 126396311 | 12639631 | 7 | 20100528 | 20100603 | 0 | |
| 126396311 | 12639631 | 9 | 20100528 | 20100603 | 0 | |
| 126396311 | 12639631 | 11 | 20100528 | 20100603 | 0 |